BPG is committed to discovery and dissemination of knowledge
Home / Archive / Volume 6, Issue 9
  • This Article
Peer-Review Report of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Journal Information of This Article
Publication Name
World Journal of Hepatology
ISSN
1948-5182
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study
©2014 Baishideng Publishing Group Inc.
World J Hepatol. Sep 27, 2014; 6(9): 670-676
Published online Sep 27, 2014. doi: 10.4254/wjh.v6.i9.670
Table 2 Sorafenib-related adverse events n (%)
Adverse eventsAny GradeGrade 1Grade 2Grade 3
Anorexia29 (78)8 (22)10 (27)11 (30)
Skin toxicitya27 (73)6 (16)8 (22)13 (35)
Fatigue23 (62)3 ( 8)11 (30)9 (24)
Diarrhea20 (54)9 (24)8 (21)3 (8)
Hypoalbuminemia19 (51)4 (11)14 (38)1 (3)
Weight loss17 (46)7 (19)9 (24)1 (3)
Hyperbilirubinemia16 (43)10 (27)5 (14)1 (3)
Decreased platelet count14 (38)3 (8)9 (24)2 (5)
Hypertension13 (35)2 (5)6 (16)5 (14)
Alopecia13 (35)5 (14)8 (22)0 (0)
Anemia9 (24)4 (11)4 (11)1 (3)
aSkin toxicity includes hand–foot skin reaction and any kind of rash.
Full Size Table
Write to the Help Desk
Copyright © 1993-2026 Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA. All rights reserved, including rights relating to text and data mining, AI training, and similar technologies. For open-access content, the applicable copyright and licensing terms govern.